TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Jacomm /Pharma AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
8,602
|
8,953
|
8,803 |
Financial expenses |
54
|
27
|
30 |
Earnings before taxes |
-148
|
591
|
268 |
EBITDA |
-105
|
622
|
306 |
Total assets |
3,620
|
3,558
|
3,376 |
Current assets |
3,587
|
3,550
|
3,360 |
Current liabilities |
2,305
|
1,403
|
1,520 |
Equity capital |
678
|
1,463
|
1,084 |
- share capital |
34
|
33
|
36 |
Employees (average) |
3
![]() |
3
![]() |
3 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
18.7%
|
41.1%
|
32.1% |
Turnover per employee |
2,867
|
2,984
|
2,934 |
Profit as a percentage of turnover |
-1.7%
|
6.6%
|
3.0% |
Return on assets (ROA) |
-2.6%
|
17.4%
|
8.8% |
Current ratio |
155.6%
|
253.0%
|
221.1% |
Return on equity (ROE) |
-21.8%
|
40.4%
|
24.7% |
Change turnover |
-397
|
863
|
321 |
Change turnover % |
-4%
|
11%
|
4% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.